Kirsten Timms

Kirsten Timms

Company: Myriad Genetics

Job title: Vice President, Biomarker Discovery


Clinical Effectiveness of myChoice® CDx Genomic Instability as a CDx Biomarker 1:00 pm

– Explore the only FDA approved HRD score CDx to prescribe PARPi’s – Understand the use of broad biomarker offering for patient selection and therapeutic response – Germline, somatic (myChoice HRD score, and gene panel), TMB, MSI – Assessing gold standard myChoice HRD vs. other HRD measuresRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.